← Back to NAGE

Niagen Bioscience, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 07/05/2025
$30$31$34$31$30$26$23$22
$1$6.3$4.6$3.6$5.1$1.9−$0−$0.5
$0.01$0.07$0.05$0.04$0.06$0.02$0.00−$0.01
8385878683787675

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.